Healthcare Global Enterprises Limited (NSE: HCG) stock breaks out, moving up 5% intraday to ₹710.0, clearing its 6M resistance trendline.
Healthcare Global Enterprises Limited (HCG) reports Q1 FY27 results with 13% revenue growth, 20% Adjusted EBITDA, and improved margins.
Healthcare Global Enterprises Limited (NSE: HCG) shows pressure after breakout, falling 5% intraday to ₹648.8.
Healthcare Global Enterprises Limited (NSE: HCG) stock rises 5% intraday to ₹626.15 despite a 6M trendline breakdown.
Healthcare Global Enterprises Limited (HCG) launches its new cancer hospital in North Bengaluru, introducing Karnataka’s first MR-Linac.